Clincosm LogoSign in Get a demo

AML

Showing 1 - 25 of 133
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, MDS Trial in Tianjin (XZB-0004)

Not yet recruiting
  • AML
  • MDS
  • Tianjin, Tianjin, China
    Hematology Hospital, Chinese Academy of Medical Sciences
Feb 13, 2023

AML, MRD Trial in Shanghai (Azacitidine, Venetoclax, Selinexor)

Not yet recruiting
  • AML
  • MRD
  • Shanghai, China
  • +3 more
Feb 12, 2023

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting
  • Hematologic Malignancy
  • +21 more
  • (no location specified)
Feb 9, 2023

AML Trial in Hangzhou (NKG2D CAR-NK)

Recruiting
  • AML
  • NKG2D CAR-NK
  • Hangzhou, Zhejiang, China
  • +1 more
Feb 17, 2023

AML Trial in Berne (Image-based ex-vivo drug screening platform (pharmacoscopy))

Recruiting
  • AML
  • Image-based ex-vivo drug screening platform (pharmacoscopy)
  • Berne, Switzerland
    Departement of Medical Oncology, University Hospital Berne
Feb 8, 2023

AML, Acute Myeloid Leukemia Trial in Boston (DREAMLAND, CERENA)

Not yet recruiting
  • AML
  • Acute Myeloid Leukemia
  • DREAMLAND
  • CERENA
  • Boston, Massachusetts
    Massachusetts General Hospital
Aug 12, 2022

AML, MDS, ALL, Adult Trial in Hackensack, New York (SOC + TSC-100, SOC + TSC-101, Control)

Recruiting
  • AML
  • +2 more
  • SOC + TSC-100
  • +2 more
  • Hackensack, New Jersey
  • +1 more
Aug 11, 2022

AML Trial in Hannover, Basel (oNKord®, Cyclophosphamide/Fludarabine (Cy/Flu))

Recruiting
  • AML
  • oNKord®
  • Cyclophosphamide/Fludarabine (Cy/Flu)
  • Hannover, Germany
  • +1 more
Aug 3, 2022

Graft Vs Host Disease, Peripheral Blood Stem Cell Transplantation, AML Trial in Germany (Cyclophosphamide, ATG)

Recruiting
  • Graft Vs Host Disease
  • +5 more
  • Augsburg, Germany
  • +15 more
Aug 2, 2022

Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

Not yet recruiting
  • Hematologic Malignancy
  • +10 more
  • Los Angeles, California
  • +28 more
Jul 26, 2022

MDS, AML Trial in Bronx (Venetoclax, Decitabine)

Recruiting
  • MDS
  • AML
  • Bronx, New York
    Montefiore Medical Center
Jul 22, 2022

MDS, AML Trial in France (venetoclax + azacitidine +/- donor lymphocyte infusion)

Not yet recruiting
  • MDS
  • AML
  • venetoclax + azacitidine +/- donor lymphocyte infusion
  • Amiens, France
  • +13 more
Jul 21, 2022

AML Trial in Hangzhou (CD33 CAR-T)

Not yet recruiting
  • AML
  • CD33 CAR-T
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Jul 21, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
  • +7 more
Jul 20, 2022

AML Trial in Hangzhou (CLL1+CD33 CAR-T)

Not yet recruiting
  • AML
  • CLL1+CD33 CAR-T
  • Hangzhou, China
    Mingming Zhang Zhang
Jul 19, 2022

AML Trial in Hangzhou (CLL1 CAR-T)

Not yet recruiting
  • AML
  • CLL1 CAR-T
  • Hangzhou, China
    The First Affiliated Hospital, Zhejiang University
Jul 17, 2022

AML Trial in Hangzhou (ADGRE2 CAR-T)

Not yet recruiting
  • AML
  • ADGRE2 CAR-T
  • Hangzhou, China
    Mingming Zhang Zhang
Jul 17, 2022

Defining Clinical Potential of Mass Response asBiomarker for

Recruiting
  • Stage III Breast Cancer
  • +5 more
    • Columbus, Georgia
      Columbus Regional Research Institute, John B. Amos Cancer Center
    Jul 13, 2022

    AML, Acute Myeloid Leukemia Trial in Charlottesville (Cardioprotection)

    Recruiting
    • AML
    • Acute Myeloid Leukemia
    • Charlottesville, Virginia
      University of Virginia
    Jul 2, 2022

    AML Trial in Wuhan (CAR--?dT cells)

    Recruiting
    • AML
    • CAR--γδT cells
    • Wuhan, Hubei, China
      Tongji Hospital
    May 24, 2022

    AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

    Recruiting
    • AML
    • +8 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 13, 2022

    Familial Investigations of Childhood Cancer Predisposition

    Recruiting
    • Acute Leukemia
    • +45 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      May 11, 2022

      AML Trial in Moscow (allo-HSCT)

      Recruiting
      • AML
      • allo-HSCT
      • Moscow, Russian Federation
        National Research Center for Hematology
      Apr 14, 2022

      AML Trial in Aurora (Venetoclax, CC-486)

      Recruiting
      • AML
      • Aurora, Colorado
      • +1 more
      Apr 4, 2022

      AML Trial in Worldwide (Flotetuzumab dose escalation, Flotetuzumab dose expansion, Ruxolitinib)

      Active, not recruiting
      • AML
      • Flotetuzumab dose escalation
      • +2 more
      • Duarte, California
      • +42 more
      Mar 7, 2022